The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7012-7023

  Xiang, Ying ^a   Simpson, David A ^a,c   Spiegel, Jason ^a,d   Zhou, Aimin ^b   Silverman, Robert H ^b   Condit, Richard C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Quidel Corporation   (United States)

^d Department of Molecular Pharmacology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; HELICASE; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; VACCINIA VIRUS; VIRUS GENE; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0031847215     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7012-7023.1998     Document Type: Article

References (60)

1. Ahn, B. Y., and B. Moss. 1992. RNA polymerase-associated transcription specificity factor encoded by vaccinia virus. Proc. Natl. Acad. Sci. USA 89:3536-3540.
2. Baldick, C. J., Jr., J. G. Keck, and B. Moss. 1992. Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. J. Virol. 66:4710-4719.
3. Baldick, C. J., Jr., and B. Moss. 1993. Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes. J. Virol. 67:3515-3527.
4. Bayliss, C. D., and R. C. Condit. 1993. Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription. Virology 194:254-262.
5. Bayliss, C. D., and R. C. Condit. 1995. The vaccinia virus A18R gene product is a DNA-dependent ATPase. J. Biol. Chem. 270:1550-1556.
6. Bayliss, C. D., and R. C. Condit. 1993. Unpublished data.
7. Beaud, G., and R. Beaud. 1997. Preferential virosomal location of underphosphorylated H5R protein synthesized in vaccinia virus-infected cells. J. Gen. Virol. 78:3297-3302.
8. Black, E. P., and R. C. Condit. 1996. Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor. J. Virol. 70:47-54.
9. Black, E. P., N. Moussatche, and R. C. Condit. 1998. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. Virology 245:313-322.
10. Broyles, S. S., J. Li, and B. Moss. 1991. Promoter DNA contacts made by the vaccinia virus early transcription factor. J. Biol. Chem. 266:15539-15544.
11. Broyles, S. S., L. Yuen, S. Shuman, and B. Moss. 1988. Purification of a factor required for transcription of vaccinia virus early genes. J. Biol. Chem. 263:10754-10760.
12. Cohrs, R. J., R. C. Condit, R. F. Pacha, C. L. Thompson, and O. K. Sharma. 1989. Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus. J. Virol. 63:948-951.
13. Condit, R. C, R. Easterly, R. F. Pacha, Z. Fathi, and R. J. Meis. 1991. A vaccinia virus isatin-β-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase. Virology 185:857-861.
14. Condit, R. C., J. I. Lewis, M. Quinn, L. M. Christen, and E. G. Niles. 1996. Use of lysolecithin-permeabilized infected-cell extracts to investigate the in vitro biochemical phenotypes of poxvirus ts mutations altered in viral transcription activity. Virology 218:169-180.
15. Condit, R. C., and A. Motyczka. 1981. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology 113:224-241.
16. Condit, R. C., A. Motyczka, and G. Spizz. 1983. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 128:429-443.
17. Condit, R. C., Y. Xiang, and J. I. Lewis. 1996. Mutation of vaccinia virus gene G2R causes suppression of gene A18R ts mutants: implications for control of transcription. Virology 220:10-19.
18. Deng, L., and S. Shuman. 1994. A role for the H4 subunit of vaccinia RNA polymerase in transcription initiation at a viral early promoter. J. Biol. Chem. 269:14323-14328.
19. Deng, L., and S. Shuman. 1998. Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination. Genes Dev. 12:538-546.
20. Eggermont, J., and N. J. Proudfoot. 1993. Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters. EMBO J. 12:2539-2548.
21. Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266.
22. Hagenbuchle, O., P. K. Wellauer, D. L. Cribbs, and U. Schibler. 1984. Termination of transcription in the mouse alpha-amylase gene Amy-2a occurs at multiple sites downstream of the polyadenylation site. Cell 38:737-744.
23. Harris, N., R. Resales, and B. Moss. 1993. Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation. Proc. Natl. Acad. Sci. USA 90:2860-2864.
24. Hassett, D. E., and R. C. Condit. 1994. Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine. Proc. Natl. Acad. Sci. USA 91:4554-4558.
25. Hirschmann, P., J. C. Vos, and H. G. Stunnenberg. 1990. Mutational analysis of a vaccinia virus intermediate promoter in vivo and in vitro. J. Virol. 64:6063-6069.
26. Jin, D. J., R. R. Burgess, J. P. Richardson, and C. A. Gross. 1992. Termination efficiency at rho-dependent terminators depends on kinetic coupling between RNA polymerase and rho. Proc. Natl. Acad. Sci. USA 89:1453-1457.
27. Keck, J. G., C. J. Baldick, and B. Moss. 1990. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell 61:801-809.
28. Koonin, E. V., and T. G. Senkevich. 1992. Vaccinia virus encodes four putative DNA and/or RNA helicases distantly related to each other. J. Gen. Virol. 73:989-993.
29. Kovacs, G. R., and B. Moss. 1996. The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. J. Virol. 70:6796-6802.
30. Levin, D., and I. M. London. 1978. Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc. Natl. Acad. Sci. USA 75:1121-1125.
31. Mahr, A., and B. E. Roberts. 1984. Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment. J. Virol. 49:510-520.
32. Moss, B. 1996. Poxviridae: the viruses and their replication, p. 2637-2672. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Strauss (ed.), Fields virology. Lippincott-Raven, New York, N.Y.
33. Nowakowski, M., W. Bauer, and J. Kates. 1978. Characterization of a DNA-binding phosphoprotein from vaccinia virus replication complex. Virology 86:217-225.
34. Nowakowski, M., J. Kates, and W. Bauer. 1978. Isolation of two DNA-binding proteins from the intracellular replication complex of vaccinia virus. Virology 84:260-267.
35. Pacha, R. F., and R. C. Condit. 1985. Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA. J. Virol. 56:395-403.
36. Proudfoot, N. J. 1989. How RNA polymerase II terminates transcription in higher eukaryotes. Trends. Biochem. Sci. 14:105-110.
37. Rochester, S. C., and P. Traktman. 1998. Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus 13 gene. J. Virol. 72:2917-2926.
38. Rosales, R., N. Harris, B. Y. Ahn, and B. Moss. 1994. Purification and identification of a vaccinia virus-encoded intermediate stage promoter-specific transcription factor that has homology to eukaryotic transcription factor SII (TFIIS) and an additional role as a viral RNA polymerase subunit. J. Biol. Chem. 269:14260-14267.
39. Rosales, R., G. Sutter, and B. Moss. 1994. A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proc. Natl. Acad. Sci. USA 91:3794-3798.
40. Sancho, C., Y. Xiang, and R. C. Condit. 1997. Unpublished data.
41. Sawadogo, M., and R. G. Roeder. 1985. Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. Proc. Natl. Acad. Sci. USA 82:4394-4398.
42. Shuman, S. 1992. Vaccinia virus RNA helicase: an essential enzyme related to the DE-H family of RNA-dependent NTPases. Proc. Natl. Acad. Sci. USA 89:10935-10939.
43. Simpson, D. A., and R. C. Condit. 1994. The vaccinia virus A18R protein plays a role in viral transcription during both the early and the late phases of infection. J. Virol. 68:3642-3649.
44. Simpson, D. A., and R. C. Condit. 1995. Vaccinia virus gene A18R encodes an essential DNA helicase. J. Virol. 69:6131-6139.
45. Smith, G. L., S. T. Howard, and Y. S. Chan. 1989. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. J. Gen. Virol. 70:2333-2343.
46. Smith, K. A., V. Stallard, J. M. Roos, C. Hart, N. Cormier, L. K. Cohen, B. E. Roberts, and L. G. Payne. 1993. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences. Vaccine 11:43-53.
47. Tamin, A., E. C. Villarreal, S. L. Weinrich, and D. E. Hruby. 1988. Nucleotide sequence and molecular genetic analysis of the vaccinia virus HindIII N/M region encoding the genes responsible for resistance to alpha-amanitin. Virology 165:141-150.
48. Turner, P. C., and R. W. Moyer. 1995. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. J. Virol. 69:5978-5987.
49. Vos, J. C., M. Sasker, and H. G. Stunnenberg. 1991. Vaccinia virus capping enzyme is a transcription initiation factor. EMBO J. 10:2553-2558.
50. Vos, J. C., and H. G. Stunnenberg. 1988. Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J. 7:3487-3492.
51. Walstrom, K. M., J. M. Dozono, S. Robic, and P. H. von Hippel. 1997. Kinetics of the RNA-DNA helicase activity of Escherichia coli transcription termination factor rho. 1. Characterization and analysis of the reaction. Biochemistry 36:7980-7992.
52. Walstrom, K. M., J. M. Dozono, and P. H. von Hippel. 1997. Kinetics of the RNA-DNA helicase activity of Escherichia coli transcription termination factor rho. 2. Processivity, ATP consumption, and RNA binding. Biochemistry 36:7993-8004.
53. Wright, C. F., A. E. Hubbs, S. K. Gunasinghe, and B. W. Oswald. 1998. A vaccinia virus late transcription factor copurifies with a factor that binds to a viral late promoter and is complemented by extracts from uninfected HeLa cells. J. Virol. 72:1446-1451.
54. Wright, C. F., and B. Moss. 1989. Identification of factors specific for transcription of the late class of vaccinia virus genes. J. Virol. 63:4224-4233.
55. Xie, Z., and D. Price. 1998. Unusual nucleic acid binding properties of factor 2, an RNA polymerase II transcript release factor. J. Biol. Chem. 273:3771-3777.
56. Xie, Z., and D. Price. 1998. Drosophila factor 2, an RNA polymerase II transcript release factor, has DNA-dependent ATPase activity. J. Biol. Chem. 272:31902-31907.
57. Xie, Z., and D. H. Price. 1996. Purification of an RNA polymerase II transcript release factor from Drosophila. J. Biol. Chem. 271:11043-11046.
58. Yuen, L., and B. Moss. 1987. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. USA 84:6417-6421.
59. Zhang, Y., J. G. Keck, and B. Moss. 1992. Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus. J. Virol. 66:6470-6479.
60. Zhou, A., J. Paranjape, T. L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares, and R. H. Silverman. 1997. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16:6355-6363.